Agitation In Alzheimer's Disease
Clinical Trial - Enrolling Now

Clinics: Barnsley, Blackpool, Cannock, Leeds and Manchester

Therapy Area: Alzheimer’s Disease

Gender and Age: Male or Female aged 50-90 years old

Reimbursement: Reasonable travel expenses such as travel by taxi, may be reimbursed. Food may be provided during long study visits if needed.

About The Research...

With an ageing population, medications to help treat the symptoms of Alzheimer’s disease (AD) become more needed than ever. Statistics show that around 80% of patients show signs of agitation and aggression with an increase in prevalence as the disease progresses. Here at MAC, we understand that the condition is incredibly difficult to deal with.

The study being run at MAC research sites in Barnsley, Blackpool, Cannock, Leeds, Liverpool and Manchester is a Phase III, 16-week study to assess a new medication that could help alleviate symptoms of agitation associated with AD. Over the 16-week period, there’ll be a total of 9 visits to a clinic nearest to you and 2 phone calls from a study doctor. The medication itself is currently known as AVP-786. By participating you may be helping to contribute to the development of a new therapy for agitation in AD that may help improve the quality of life for many people.

A full description of the study will be given at the visit before you decide to participate. At that time, you will also receive the full patient information sheet (PIS).

Criteria:

Key Inclusion Criteria:

  • Men and women aged between 50-90
  • A diagnosis of Alzheimer’s disease
  • Symptoms of agitation associated with Alzheimer’s disease

 

Key Exclusion Criteria:

  • An uncontrolled or unstable medical condition
  • Dementia of the non-Alzheimer’s type: vascular, frontotemporal, Parkinson’s etc

Other eligibility criteria will apply. Please contact MAC for more information.

Any other information:

Eligible patients will receive a health screen and study participation will be in collaboration with the patient’s treating physician.

Reimbursement:

Reasonable travel expenses such as travel by taxi, may be reimbursed. Food may be provided during long study visits if needed.

Key Inclusion Criteria

  •  

Key Exclusion Criteria

  •  


MAC Clinical Research is currently conducting a trial to test a new potential treatment for agitation in Alzheimer’s disease.

If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • (You can enter any supporting information here)
Data Privacy Statement

Know someone who may be interested in taking part? Share this page here:

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on email
Email